Wu C, Li M, Meng H, Liu Y, Niu W, Zhou Y et al (2019) Analysis of status and countermeasures of cancer incidence and mortality in China. Sci China Life Sci 62(5):640–647

Article  PubMed  Google Scholar 

Yuan M, Huang LL, Chen JH, Wu J, Xu Q (2019) The emerging treatment landscape of targeted therapy in non-small-cell lung cancer. Signal Transduct Target Ther 4:61

Article  PubMed  PubMed Central  Google Scholar 

Grenda A, Blach J, Szczyrek M, Krawczyk P, Nicos M, Kuznar Kaminska B et al (2020) Promoter polymorphisms of TOP2A and ERCC1 genes as predictive factors for chemotherapy in non-small cell lung cancer patients. Cancer Med 9(2):605–614

Article  CAS  PubMed  Google Scholar 

Jonas DE, Reuland DS, Reddy SM, Nagle M, Clark SD, Weber RP et al (2021) Screening for lung cancer with low-dose computed tomography: updated evidence report and systematic review for the US preventive services task force. JAMA 325(10):971–987

Article  PubMed  Google Scholar 

Chetan MR, Gleeson FV (2021) Radiomics in predicting treatment response in non-small-cell lung cancer: current status, challenges and future perspectives. Eur Radiol 31(2):1049–1058

Article  PubMed  Google Scholar 

Bab S, Abdifard E, Moradi Y, Faraj A, Heidari M (2016) Lung cancer incidence trends in Iran and in six geographical regions of the country (2000–2005). Shiraz E Med J 17(6):e38237

Article  Google Scholar 

Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JH, Beasley MB et al (2015) The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol 10(9):1243–1260

Article  PubMed  Google Scholar 

Alberg AJ, Brock MV, Ford JG, Samet JM, Spivack SD (2013) Epidemiology of lung cancer: diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143(5):e1S-e29S

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Ma R, Liu B, Kong J, Lin H, Yu X et al (2020) SNP rs17079281 decreases lung cancer risk through creating an YY1-binding site to suppress DCBLD1 expression. Oncogene 39(20):4092–4102

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rahal Z, El Nemr S, Sinjab A, Chami H, Tfayli A, Kadara H (2017) Smoking and lung cancer: a geo-regional perspective. Front Oncol 7:194

Article  PubMed  PubMed Central  Google Scholar 

Yang IA, Holloway JW, Fong KM (2013) Genetic susceptibility to lung cancer and co-morbidities. J Thorac Dis 5(Suppl 5):S454

PubMed  PubMed Central  Google Scholar 

Bashir NA, Ragab ES, Khabour OF, Khassawneh BY, Alfaqih MA, Momani JA (2018) The association between epidermal growth factor receptor (EGFR) gene polymorphisms and lung cancer risk. Biomolecules 8(3):53

Article  PubMed  PubMed Central  Google Scholar 

Jin G, Wang H, Hu Z, Liu H, Sun W, Ma H et al (2008) Potentially functional polymorphisms of EXO1 and risk of lung cancer in a Chinese population: a case-control analysis. Lung Cancer 60(3):340–346

Article  PubMed  Google Scholar 

Ribeiro R, Araújo AP, Coelho A, Catarino R, Pinto D, Araújo A et al (2006) A functional polymorphism in the promoter region of leptin gene increases susceptibility for non-small cell lung cancer. Eur J Cancer 42(8):1188–1193

Article  CAS  PubMed  Google Scholar 

Bian X, Wang F, Yang C, Wang X, Guo H, Xing Y, Liu R, Chen S (2013) -216G/T (rs712829), a functional variant of the EGFR promoter, is associated with the pleural metastasis of lung adenocarcinoma. Oncol Lett 6:693–698

Article  PubMed  PubMed Central  Google Scholar 

Tsiambas E, Mastronikolis NS, Lefas AY, Georgiannos SN, Ragos V, Fotiades PP et al (2017) Chromosome 7 multiplication in EGFR-positive lung carcinomas based on tissue microarray analysis. In Vivo 31(4):641–648

Article  CAS  PubMed  PubMed Central  Google Scholar 

McKibbin T, Zhao W, Tagen M, Daw NC, Furman WL, McGregor LM et al (2010) Epidermal growth factor receptor polymorphisms and risk for toxicity in paediatric patients treated with gefitinib. Eur J Cancer 46(11):2045–2051

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bowen N, Smith CE, Srivatsan A, Willcox S, Griffith JD, Kolodner RD (2013) Reconstitution of long and short patch mismatch repair reactions using Saccharomyces cerevisiae proteins. Proc Natl Acad Sci 110(46):18472–18477

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang J, Tang S, Liu J, Wu Q, Wan L, Xu Q (2015) Genetic risk of lung cancer associated with a single nucleotide polymorphism from EXO1: a meta analysis. Int J Clin Exp Med 8(7):11132

CAS  PubMed  PubMed Central  Google Scholar 

Wei K, Clark AB, Wong E, Kane MF, Mazur DJ, Parris T et al (2003) Inactivation of Exonuclease 1 in mice results in DNA mismatch repair defects, increased cancer susceptibility, and male and female sterility. Genes Dev 17(5):603–614

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bau D-T, Wang H-C, Liu C-S, Chang C-L, Chiang S-Y, Wang R-F et al (2009) Single-nucleotide polymorphism of the Exo1 gene: association with gastric cancer susceptibility and interaction with smoking in Taiwan. Chin J Physiol 52(6):411–418

Article  CAS  PubMed  Google Scholar 

Tsai M-H, Tseng H-C, Liu C-S, Chang C-L, Tsai C-W, Tsou Y-A et al (2009) Interaction of Exo1 genotypes and smoking habit in oral cancer in Taiwan. Oral Oncol 45(9):e90–e94

Article  CAS  PubMed  Google Scholar 

Wang H-C, Chiu C-F, Tsai R-Y, Kuo Y-S, Chen H-S, Wang R-F et al (2009) Association of genetic polymorphisms of EXO1 gene with risk of breast cancer in Taiwan. Anticancer Res 29(10):3897–3901

CAS  PubMed  Google Scholar 

Hsu N-Y, Wang H-C, Wang C-H, Chiu C-F, Tseng H-C, Liang S-Y et al (2009) Lung cancer susceptibility and genetic polymorphisms of Exo1 gene in Taiwan. Anticancer Res 29(2):725–730

CAS  PubMed  Google Scholar 

Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland L et al (2006) Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 27(3):560–567

Article  CAS  PubMed  Google Scholar 

Dutta D, Ghosh S, Pandit K, Mukhopadhyay P, Chowdhury S (2012) Leptin and cancer: pathogenesis and modulation. Indian J Endocrinol Metab 16(Suppl 3):S596

PubMed  PubMed Central  Google Scholar 

Mendonsa AM, Chalfant MC, Gorden LD, VanSaun MN (2015) Modulation of the leptin receptor mediates tumor growth and migration of pancreatic cancer cells. PLoS ONE 10(4):e0126686

Article  PubMed  PubMed Central  Google Scholar 

Ray A, Cleary MP (2017) The potential role of leptin in tumor invasion and metastasis. Cytokine Growth Factor Rev 38:80–97

Article  CAS  PubMed  PubMed Central  Google Scholar 

Herrera-Covarrubias D, Coria-Avila GA, Fernández-Pomares C, Aranda-Abreu GE, Hernández M (2015) Obesity as a risk factor in the development of cancer. Rev Peru Med Exp Salud Publica 32(4):766–776

Article  PubMed  Google Scholar 

He J, Xi B, Ruiter R, Shi T-Y, Zhu M-L, Wang M-Y et al (2013) Association of LEP G2548A and LEPR Q223R polymorphisms with cancer susceptibility: evidence from a meta-analysis. PLoS ONE 8(10):e75135

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hussain SR, Naqvi H, Gupta S, Mahdi AA, Kumari P, Waseem M et al (2015) A study on oncogenic role of leptin and leptin receptor in oral squamous cell. Tumor Biol 36:6515–6523

Article  CAS  Google Scholar 

Jiang N, Sun R, Sun Q (2014) Leptin signaling molecular actions and drug target in hepatocellular carcinoma. Drug Des Dev Ther 8:2295–302

Google Scholar 

Domingos P, Farias L, Pereira C, das Graças Pena G, Reis T, Silva R et al (2014) Leptin receptor polymorphism Gln223Arg (rs1137101) in oral squamous cell carcinoma and potentially malignant oral lesions. Springerplus 3:683

Article  PubMed  PubMed Central  Google Scholar 

Kamel HFM, Nassir AM, Al Refai AA (2020) Assessment of expression levels of leptin and leptin receptor as potential biomarkers for risk of prostate cancer development and aggressiveness. Cancer Med 9(15):5687–5696

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rong G, Tang W, Wang Y, Qiu H, Chen S (2019) Investigation of leptin receptor rs1137101 G> A polymorphism with cancer risk: evidence from 35936 subjects. Biosci Rep 39(6):BSR20182240

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jin TY, Saindane M, Park KS, Kim S, Nam S, Yoo Y et al (2021) LEP as a potential biomarker in prognosis of breast cancer: systemic review and meta analyses (PRISMA). Medicine 100(33)

Huang H, Zhang J, Ling F, Huang Y, Yang M, Zhang Y et al (2021) Leptin Receptor (LEPR) promotes proliferation, migration, and invasion and inhibits apoptosis in hepatocellular carcinoma by regulating ANXA7. Cancer Cell Int 21(1):1–9

Article  Google Scholar 

Rodrigues P, Maia L, Santos Md, Peterle G, Alves L, Takamori J et al (2015) Leptin receptor expression and Gln223Arg polym